- Home
- PBYI vs ANTA Comparison
PBYI vs ANTA Comparison
Compare PBYI & ANTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PBYI | ANTA |
|---|---|---|
| Founded | 2010 | 2022 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 263.4M | 227.5M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | PBYI | ANTA |
|---|---|---|
| Price | $6.42 | $9.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $7.00 | ★ $17.50 |
| AVG Volume (30 Days) | ★ 376.3K | 5.2K |
| Earning Date | 02-26-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 59.87 | ★ 669.18 |
| EPS | ★ 0.74 | 0.47 |
| Revenue | ★ $211,995,000.00 | $65,033,103.00 |
| Revenue This Year | N/A | $69.27 |
| Revenue Next Year | N/A | $64.32 |
| P/E Ratio | ★ $8.38 | $20.15 |
| Revenue Growth | N/A | ★ 63.28 |
| 52 Week Low | $2.58 | $8.50 |
| 52 Week High | $6.30 | $27.72 |
Technical Indicators
Market Signals| Indicator | PBYI | ANTA |
|---|---|---|
| Relative Strength Index (RSI) | 67.23 | 48.47 |
| Support Level | $6.05 | $9.38 |
| Resistance Level | $6.29 | $9.70 |
| Average True Range (ATR) | 0.25 | 0.22 |
| MACD | 0.02 | 0.06 |
| Stochastic Oscillator | 96.25 | 66.28 |
Price Performance
Historical ComparisonAbout PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About ANTA Antalpha Platform Holding Company Ordinary Shares
Antalpha Platform Holding Co provides financing, technology and risk management solutions to the digital asset industry. It is a provider of supply chain financing solutions to institutional and corporate participants in the Bitcoin mining industry, offering loans secured by Bitcoin and Bitcoin mining machines. It has developed a technology platform, Antalpha Prime, which enables customers to apply for and manage their digital asset loans while allowing to closely monitor collateral positions.